Zhejiang AngLiKang Pharmaceutical CO.,LTD.
SZSE:002940.SZ
17.9 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||
| Current Assets: | ||||||||||
| Cash & Cash Equivalents
| 859.746 | 735.467 | 688.908 | 854.066 | 527.697 | 618.33 | 139.478 | 59.739 | 30.418 | 39.995 |
| Short Term Investments
| 10 | 69.297 | 59.6 | -1.535 | 100.054 | 55.077 | -2.052 | 7.85 | 36.4 | 0 |
| Cash and Short Term Investments
| 869.746 | 804.764 | 748.508 | 854.066 | 627.752 | 618.33 | 139.478 | 59.739 | 30.418 | 39.995 |
| Net Receivables
| 275.374 | 344.256 | 312.139 | 264.877 | 203.833 | 285.891 | 268.61 | 173.475 | 237.483 | 196.357 |
| Inventory
| 393.443 | 293.229 | 299.602 | 262.998 | 139.004 | 171.809 | 152.744 | 137.504 | 144.718 | 152.859 |
| Other Current Assets
| 23.368 | 9.708 | 15.706 | 11.456 | 7.071 | 3.953 | 2.037 | 30.703 | 49.408 | 11.973 |
| Total Current Assets
| 1,561.931 | 1,451.957 | 1,375.956 | 1,393.397 | 977.661 | 1,079.983 | 562.869 | 401.421 | 462.027 | 401.183 |
| Non-Current Assets: | ||||||||||
| Property, Plant & Equipment, Net
| 615.8 | 445.703 | 474.634 | 389.508 | 304.581 | 272.538 | 247.793 | 229.81 | 234.682 | 231.098 |
| Goodwill
| 312.942 | 21.976 | 21.976 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 168.139 | 38.779 | 40.055 | 36.881 | 38.865 | 40.151 | 41.891 | 43.75 | 45.677 | 48.817 |
| Goodwill and Intangible Assets
| 481.081 | 60.755 | 62.031 | 36.881 | 38.865 | 40.151 | 41.891 | 43.75 | 45.677 | 48.817 |
| Long Term Investments
| 291.406 | 232.852 | 87.742 | 96.52 | -56.405 | 0 | 51.363 | 50.778 | 55.465 | 42.059 |
| Tax Assets
| 32.77 | 22.442 | 20.651 | 22.879 | 17.262 | 20.253 | 2.216 | 1.235 | 1.571 | 2.444 |
| Other Non-Current Assets
| 37.003 | 382.374 | 62.565 | 1.569 | 103.021 | 57.275 | 0.652 | 0.994 | 0.409 | 5.838 |
| Total Non-Current Assets
| 1,458.06 | 1,144.126 | 707.623 | 547.358 | 407.325 | 390.218 | 343.916 | 326.566 | 337.804 | 330.257 |
| Total Assets
| 3,019.991 | 2,596.083 | 2,083.578 | 1,940.754 | 1,384.985 | 1,470.201 | 906.785 | 727.987 | 799.831 | 731.44 |
| Liabilities & Equity: | ||||||||||
| Current Liabilities: | ||||||||||
| Account Payables
| 402.486 | 320.45 | 335.975 | 322.731 | 144.322 | 240.123 | 235.865 | 229.804 | 263.016 | 213.875 |
| Short Term Debt
| 163.805 | 195.202 | 98.137 | 10.006 | 69.833 | 15 | 80 | 113.327 | 189.8 | 219.227 |
| Tax Payables
| 14.952 | 35.523 | 29.291 | 22.304 | 14.794 | 24.954 | 6.774 | 0.572 | 0.406 | 8.062 |
| Deferred Revenue
| 164.316 | 33.067 | 23.293 | 211.279 | 17.05 | 24.954 | 175.956 | 24.345 | 18.217 | 39.744 |
| Other Current Liabilities
| 1.364 | 239.87 | 137.881 | 1.174 | 123.965 | 206.29 | 11.708 | 16.791 | 21.191 | 3.887 |
| Total Current Liabilities
| 731.971 | 788.589 | 595.286 | 545.19 | 355.171 | 486.367 | 503.528 | 384.268 | 492.225 | 476.734 |
| Non-Current Liabilities: | ||||||||||
| Long Term Debt
| 423.95 | 150 | 0 | 0 | 0 | 0 | 0 | 9.315 | 37.829 | 32 |
| Deferred Revenue Non-Current
| 17.847 | 9.733 | 13.301 | 17.594 | 13.342 | 12.907 | 8.886 | 6.974 | 5.58 | 5.626 |
| Deferred Tax Liabilities Non-Current
| 13.953 | 1.605 | 0.056 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 455.75 | 161.338 | 13.357 | 17.594 | 13.342 | 12.907 | 8.886 | 16.289 | 43.409 | 37.626 |
| Total Liabilities
| 1,187.721 | 949.927 | 608.643 | 562.784 | 368.513 | 499.274 | 512.415 | 400.557 | 535.634 | 514.359 |
| Equity: | ||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 201.728 | 139.123 | 95.947 | 95.947 | 90 | 90 | 67.5 | 67.5 | 67.5 | 67.5 |
| Retained Earnings
| 605.938 | 519.67 | 432.375 | 359.475 | 288.729 | 247.919 | 150.314 | 99.856 | 47.53 | -8.763 |
| Accumulated Other Comprehensive Income/Loss
| 105.176 | 91.829 | 78.64 | 68.228 | 52.553 | 86.737 | 152.373 | 143.491 | 132.437 | 2.391 |
| Other Total Stockholders Equity
| 673.362 | 752.039 | 731.891 | 795.23 | 533.844 | 494.411 | 0 | 0 | 0 | 119.364 |
| Total Shareholders Equity
| 1,586.203 | 1,502.661 | 1,338.853 | 1,318.879 | 965.125 | 919.068 | 370.187 | 310.847 | 247.466 | 180.491 |
| Total Equity
| 1,832.27 | 1,646.156 | 1,474.936 | 1,377.97 | 1,016.473 | 970.927 | 394.37 | 327.43 | 264.197 | 217.08 |
| Total Liabilities & Shareholders Equity
| 3,019.991 | 2,596.083 | 2,083.578 | 1,940.754 | 1,384.985 | 1,470.201 | 906.785 | 727.987 | 799.831 | 731.44 |